Literature DB >> 8800837

Bacterial superantigens in human disease: structure, function and diversity.

R G Ulrich1, S Bavari, M A Olson.   

Abstract

All bacterial superantigens use common structural strategies to bind to major histocompatibility complex class II receptors, while binding the T cell antigen receptor in different ways. Overstimulation of the immune response is responsible for the acute pathological effects, while reactivation of developmentally silenced T cells might result in autoimmune disease. Certain diseases might be controlled with superantigens or genetically attenuated vaccines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8800837     DOI: 10.1016/s0966-842x(00)89011-3

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  14 in total

1.  Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators.

Authors:  Dorothy D Pless; Gordon Ruthel; Emily K Reinke; Robert G Ulrich; Sina Bavari
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality.

Authors:  R D LeClaire; S Bavari
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Selective CD8+ T cells accumulate in the lungs of patients with allergic asthma after allergen bronchoprovocation.

Authors:  J Wahlström; B Dahlén; E Ihre; H Wigzell; J Grunewald; A Eklund
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

4.  Evaluation of the Potency, Neutralizing Antibody Response, and Stability of a Recombinant Fusion Protein Vaccine for Streptococcus pyogenes.

Authors:  E Burlet; H HogenEsch; A Dunham; G Morefield
Journal:  AAPS J       Date:  2017-03-10       Impact factor: 4.009

5.  Staphylococcal enterotoxin A induction of pro-inflammatory cytokines and lethality in mice is primarily dependent on MyD88.

Authors:  Teri L Kissner; Emily D Cisney; Robert G Ulrich; Stefan Fernandez; Kamal U Saikh
Journal:  Immunology       Date:  2010-05-03       Impact factor: 7.397

6.  Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination.

Authors:  Ross D LeClaire; Robert E Hunt; Sina Bavari
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

7.  A small molecule that mimics the BB-loop in the Toll interleukin-1 (IL-1) receptor domain of MyD88 attenuates staphylococcal enterotoxin B-induced pro-inflammatory cytokine production and toxicity in mice.

Authors:  Teri L Kissner; Lionel Moisan; Enrique Mann; Shahabuddin Alam; Gordon Ruthel; Robert G Ulrich; Mitra Rebek; Julius Rebek; Kamal U Saikh
Journal:  J Biol Chem       Date:  2011-06-21       Impact factor: 5.157

8.  Adipose Tissue-Derived Mesenchymal Stem Cells Attenuate Staphylococcal Enterotoxin A-Induced Toxic Shock.

Authors:  Krisana Asano; Sayuri Yoshimura; Akio Nakane
Journal:  Infect Immun       Date:  2015-06-22       Impact factor: 3.441

9.  Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome.

Authors:  Garry L Morefield; Lynn D Hawkins; Sally T Ishizaka; Teri L Kissner; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

10.  Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88.

Authors:  Teri L Kissner; Gordon Ruthel; Shahabuddin Alam; Enrique Mann; Dariush Ajami; Mitra Rebek; Eileen Larkin; Stefan Fernandez; Robert G Ulrich; Sun Ping; David S Waugh; Julius Rebek; Kamal U Saikh
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.